Type 2 Diabetes mellitus Samples

The category Type 2 Diabetes mellitus Samples includes human serum specimens which were measured for the following laboratory parameters: Hepatitis B Virus surface Antigen, Hepatitis C Virus ribonucleic acid, HIV-1-RNA, Neuron-specific enolase and Prostate specific antigen. You can use our filter functions to perform complex searches according to laboratory parameters, diseases, medication such as Actaphane, Actrapid, Actrapiol, Adenuric or Apidra, ICD-10 code, donor age and gender as well as donor ethnicity and BMI. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact our Central BioHub team.

Available filters
-
-
377 Products

Human Serum - E11.90

Donor:
Gender: Female Age: 63 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
63 Years
Ethnic group:
European/Caucasian
BMI:
56 kg/m²
Weight:
152 kg
Height:
165 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • hypertension
  • sleep apnoea
Medication:
  • insulin
  • metformin
Therapy:
  • cardiac valve replacement
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH146089
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E11.90

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Humalog
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
70 kg
Height:
164 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • E11.90
Medication:
  • Humalog (active agent: insulin lispro)
  • Lantus (active agent: insulin glargin)
  • Metex (Dosages: 20mg/week)
  • Orencia (Dosages: 750mg/4 weeks, active agent: abatacept)
  • Prednisolon (Dosages: 1mg, as needed)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: positive
Quant: 33.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 4.71 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 6.10 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 35.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total IgM
Qual: positive
Quant: 32.00 mg/dl
Source: this donation
40.00 - 230.00 mg/dl
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295179
1 mL ($43.13)
Available ($225.00)

Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
41 kg/m²
Weight:
112 kg
Height:
165 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • thyroid disease
Medication:
  • L-thyroxine
  • Toujeo (specific information from donor: Toujeo 300 U/ml)
  • atorvastatin
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Blood sugar (fasting)
Qual:
Quant: 135.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.60 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165497
1 mL ($43.13)
Available ($225.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E78.2

Donor:
Gender: Female Age: 41 Ethnic group: Not specified
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Prednisolon
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
41 Years
Ethnic group:
Not specified
BMI:
32 kg/m²
Weight:
84 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Mixed hyperlipidaemia [E78.2]
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Prednisolon (specific information from donor: Prednisolon 5 mg)
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 173 mg/dl
Source: this donation
Method: not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165459
1 mL ($43.13)
Available ($225.00)

Human Serum - Blood sugar (fasting), Glycosylated h... - E11.9

Donor:
Gender: Female Age: 74 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
incretin mimetics
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood sugar (fasting) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
74 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
68.8 kg
Height:
155 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • hypothyroidism
Medication:
  • incretin mimetics
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Blood sugar (fasting)
Qual:
Quant: 78.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165492
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 68 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
DPP-4 inhibitor
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
68 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
98 kg
Height:
180 cm
Sample:
Matrix:
Serum
Condition:
not specified
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • thyroid disease
Medication:
  • DPP-4 inhibitor
  • blood thinner (because of stroke)
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 3.10 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH282850
1 mL ($43.13)
Available ($225.00)

Human Serum - E11.90

Donor:
Gender: Female Age: 75 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
L-thyroxine
Parameter:
Hepatitis B Virus surface Antigen (HBsAg) Hepatitis C Virus ribonucleic acid (HCV-RNA) Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Donor:
Gender:
Female
Age:
75 Years
Ethnic group:
European/Caucasian
BMI:
18 kg/m²
Weight:
52 kg
Height:
160 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.90
  • atrial fibrillation
Medication:
  • L-thyroxine (specific information from donor: L-thyroxine 100)
  • metformin
  • no insulin
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Hepatitis C Virus ribonucleic acid (HCV-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: qPCR (Real-Time Quantitative PCR)
System: Cobas Ampliprep/Cobas TaqMan Roche
Human Immunodeficiency Virus type 1 ribonucleic acid (HIV-1-RNA)
Qual: negative
Quant:
Source: this donation
negative
Method: PCR (Polymerase Chain Reaction)
System: Cobas Ampliprep/Cobas TaqMan Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165346
1 mL ($86.25)
Available ($225.00)

Human K3EDTA plasma - Erythrocyte sedimentation rate (ESR) ... - E11.90

Donor:
Gender: Female Age: 72 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Dekristol
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
72 Years
Ethnic group:
European/Caucasian
BMI:
30 kg/m²
Weight:
67 kg
Height:
150 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • E11.90
Medication:
  • Dekristol (Dosages: 20000/week, acitve agent: vitamin D3)
  • hydroxychloroquine (Dosages: 400/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 0.90 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 1.68 mg/L
Source: previous donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 75.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: positive
Quant: 62.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total IgM
Qual: negative
Quant: 83.00 mg/dl
Source: this donation
40.00 - 230.00 mg/dl
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: positive
Quant: 54.00 IU/mL
Source: previous donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295181
1 mL ($43.13)
Available ($225.00)

Human Serum - E11.9

Donor:
Gender: Male Age: 80 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Actrapid
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
80 Years
Ethnic group:
European/Caucasian
BMI:
28 kg/m²
Weight:
98 kg
Height:
187 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Actrapid
  • Toujeo
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH284126
1 mL ($43.13)
Available ($225.00)

Human Serum - E11.21

Donor:
Gender: Female Age: 76 Ethnic group: Not specified
Diagnosed disease:
E11.21
Medication:
Januvia
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
76 Years
Ethnic group:
Not specified
BMI:
27 kg/m²
Weight:
68 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.21]
Medication:
  • Januvia (specific information from donor: Januvia 50 mg)
  • Losartan (specific information from donor: Losartan 100 mg)
  • Prednisolon (specific information from donor: Prednisolon 1 mg)
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165523
1 mL ($43.13)
Available ($225.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 60 Ethnic group: Not specified
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
metformin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
60 Years
Ethnic group:
Not specified
BMI:
30 kg/m²
Weight:
79 kg
Height:
162 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 107.00 mg/dl
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165575
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Male Age: 49 Ethnic group: Asian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
L-thyroxine
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
49 Years
Ethnic group:
Asian
BMI:
26 kg/m²
Weight:
99 kg
Height:
196 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • L-thyroxine
  • Victoza
  • insulin
  • metformin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165485
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Male Age: 59 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
Novorapid
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
59 Years
Ethnic group:
European/Caucasian
BMI:
35 kg/m²
Weight:
117 kg
Height:
184 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • Novorapid
  • Toujeo
  • Trulicity
  • insulin
  • metformin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.6 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283499
1 mL ($43.13)
Available ($225.00)

Human Serum - Blood glucose (postprandial), Glycosy... - E11.9

Donor:
Gender: Female Age: 73 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Lantus
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Blood glucose (postprandial) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
73 Years
Ethnic group:
European/Caucasian
BMI:
38 kg/m²
Weight:
71.5 kg
Height:
138 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.9] - type 2 (not specified)
Medication:
  • Lantus
  • Liprolog
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Blood glucose (postprandial)
Qual:
Quant: 149.00 mg/dl
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.20 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH170850
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Female Age: 54 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
no incretin mimetics
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
54 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
78 kg
Height:
164 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Anamneses:
  • dietary change diet (information given at the time of donation)
Diseases:
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • no incretin mimetics
  • no insulin
Therapy:
  • gastric bypass
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.90 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH198043
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.9

Donor:
Gender: Female Age: 57 Ethnic group: European/Caucasian
Diagnosed disease:
E11.9 - Type 2 diabetes mellitus without complications - type 2 (not specified)
Medication:
Irbesartan
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
57 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
85 kg
Height:
163 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hashimotos thyroiditis
  • Mnires disease
  • diabetes mellitus [E11.9] - type 2 (not specified)
  • hyperlipidaemia
  • hypertension
Medication:
  • Irbesartan
  • L-thyroxine (Dosages: 125not specified)
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.50 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH170899
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - D35.2

Donor:
Gender: Male Age: 59 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
59 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
103 kg
Height:
180 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Benign neoplasm of pituitary gland [D35.2]
  • I10.90
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
  • hypertension
  • pituitary adenoma
Medication:
  • insulin
  • metformin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.30 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283998
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E03.9

Donor:
Gender: Female Age: 67 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
L-thyroxine
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
67 Years
Ethnic group:
European/Caucasian
BMI:
36 kg/m²
Weight:
84 kg
Height:
153 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E66.99
  • I10.90
  • Disorder of kidney and ureter, unspecified [N28.9]
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • L-thyroxine (Dosages: 5mg)
  • amlodipine (Dosages: 5mg)
  • metformin
  • no incretin mimetics
  • no insulin
  • rosuvastatin (Dosages: 5mg)
  • spironolactone (Dosages: 5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: positive
Quant: 7.40 %
Source: this donation
4.00 - 6.00 not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH333856
1 mL ($43.13)
Available ($225.00)

Human Li-heparin plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E03.9

Donor:
Gender: Female Age: 67 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
L-thyroxine
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
67 Years
Ethnic group:
European/Caucasian
BMI:
36 kg/m²
Weight:
84 kg
Height:
153 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E66.99
  • I10.90
  • Disorder of kidney and ureter, unspecified [N28.9]
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • L-thyroxine (Dosages: 5mg)
  • amlodipine (Dosages: 5mg)
  • metformin
  • no incretin mimetics
  • no insulin
  • rosuvastatin (Dosages: 5mg)
  • spironolactone (Dosages: 5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: positive
Quant: 7.40 %
Source: this donation
4.00 - 6.00 not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303130
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E03.9

Donor:
Gender: Female Age: 67 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
L-thyroxine
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
67 Years
Ethnic group:
European/Caucasian
BMI:
36 kg/m²
Weight:
84 kg
Height:
153 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hypothyroidism, unspecified [E03.9]
  • E66.99
  • I10.90
  • Disorder of kidney and ureter, unspecified [N28.9]
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • L-thyroxine (Dosages: 5mg)
  • amlodipine (Dosages: 5mg)
  • metformin
  • no incretin mimetics
  • no insulin
  • rosuvastatin (Dosages: 5mg)
  • spironolactone (Dosages: 5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: positive
Quant: 7.40 %
Source: this donation
4.00 - 6.00 not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303129
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E78.2

Donor:
Gender: Male Age: 58 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (not specified)
Medication:
metformin
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
58 Years
Ethnic group:
European/Caucasian
BMI:
26 kg/m²
Weight:
94 kg
Height:
190 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Mixed hyperlipidaemia [E78.2]
  • bronchial asthma
  • diabetes mellitus [E11.90] - type 2 (not specified)
  • postthrombotic syndrome
  • renal insufficiency - grade III (not specified)
Medication:
  • metformin
  • no incretin mimetics
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.90 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott Diagnostics
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH165472
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.

Donor:
Gender: Female Age: 70 Ethnic group: European/Caucasian
Diagnosed disease:
E11. - type 2 (not specified)
Medication:
Insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Female
Age:
70 Years
Ethnic group:
European/Caucasian
BMI:
32 kg/m²
Weight:
79 kg
Height:
158 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • diabetes mellitus [E11.] - type 2 (not specified)
  • fibromyalgia
  • hepatic cirrhosis - early stadium (not specified)
  • hepatic fibrosis
  • hypertension
  • spinal stenosis
Medication:
  • Insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 6.10 %
Source:
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH169862
1 mL ($43.13)
Available ($225.00)

Human K2EDTA plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E11

Donor:
Gender: Female Age: 38 Ethnic group: European/Caucasian
Diagnosed disease:
E11 - type 2 (not specified)
Medication:
Ramipril
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
38 Years
Ethnic group:
European/Caucasian
BMI:
31.05 kg/m²
Blood type:
B
Rhesus factor:
positive
Weight:
94 kg
Height:
174 cm
Sample:
Matrix:
K2EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Collection System:
S-Monovette 9ml K2E-Gel, 1,6 mg/ml blood, Sarstedt (Art.-Nr.: 02.1333.001)
Diseases:
  • diabetes mellitus [E11] - type 2 (not specified)
  • hypertension
Medication:
  • Ramipril (Dosages: 10mg/day)
  • Trulicity (Dosages: 0.75/week)
  • incretin mimetics
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.50 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344203
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E11

Donor:
Gender: Female Age: 38 Ethnic group: European/Caucasian
Diagnosed disease:
E11 - type 2 (not specified)
Medication:
Ramipril
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
38 Years
Ethnic group:
European/Caucasian
BMI:
31.05 kg/m²
Blood type:
B
Rhesus factor:
positive
Weight:
94 kg
Height:
174 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Collection System:
S-Monovette 7.5ml K3E, 1,6 mg/ml blood, Sarstedt (Art.-Nr.: 01.1605.001)
Diseases:
  • diabetes mellitus [E11] - type 2 (not specified)
  • hypertension
Medication:
  • Ramipril (Dosages: 10mg/day)
  • Trulicity (Dosages: 0.75/week)
  • incretin mimetics
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.50 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344204
1 mL ($43.13)
Available ($225.00)

Human Li-heparin plasma - Glycosylated hemoglobin (HbA1, HbA1c) - E11

Donor:
Gender: Female Age: 38 Ethnic group: European/Caucasian
Diagnosed disease:
E11 - type 2 (not specified)
Medication:
Ramipril
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
38 Years
Ethnic group:
European/Caucasian
BMI:
31.05 kg/m²
Blood type:
B
Rhesus factor:
positive
Weight:
94 kg
Height:
174 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Collection System:
S-Monovette 9ml LH, 16 IU/ml blood, Sarstedt (Art.-Nr.: 02.1065.001)
Diseases:
  • diabetes mellitus [E11] - type 2 (not specified)
  • hypertension
Medication:
  • Ramipril (Dosages: 10mg/day)
  • Trulicity (Dosages: 0.75/week)
  • incretin mimetics
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.50 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344205
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11

Donor:
Gender: Female Age: 38 Ethnic group: European/Caucasian
Diagnosed disease:
E11 - type 2 (not specified)
Medication:
Ramipril
Parameter:
Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
38 Years
Ethnic group:
European/Caucasian
BMI:
31.05 kg/m²
Blood type:
B
Rhesus factor:
positive
Weight:
94 kg
Height:
174 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Preanalytics:
Collection System:
S-Monovette 9ml Z-Gel, Sarstedt (Art.-Nr.: 02.1388.001)
Diseases:
  • diabetes mellitus [E11] - type 2 (not specified)
  • hypertension
Medication:
  • Ramipril (Dosages: 10mg/day)
  • Trulicity (Dosages: 0.75/week)
  • incretin mimetics
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.50 %
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344202
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - E11.90

Donor:
Gender: Female Age: 58 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
metformin
Parameter:
Anti-Thyroglobulin (aTg / TAK) Glycosylated hemoglobin (HbA1, HbA1c)
Donor:
Gender:
Female
Age:
58 Years
Ethnic group:
European/Caucasian
BMI:
29 kg/m²
Weight:
79 kg
Height:
164 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Hashimotos thyroiditis
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • metformin
  • no insulin
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: < 20.00 kU/L
Source: this donation
< 40.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 5.50 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH145939
1 mL ($43.13)
Available ($225.00)

Human Serum - Glycosylated hemoglobin (HbA1, HbA1c) - I10.90

Donor:
Gender: Male Age: 55 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90 - type 2 (reliable diagnosis)
Medication:
insulin
Parameter:
Anti-Hepatitis C Virus (HCV) Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2) Glycosylated hemoglobin (HbA1, HbA1c) Hepatitis B Virus surface Antigen (HBsAg)
Donor:
Gender:
Male
Age:
55 Years
Ethnic group:
European/Caucasian
BMI:
41 kg/m²
Weight:
136 kg
Height:
182 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • I10.90
  • diabetes mellitus [E11.90] - type 2 (reliable diagnosis)
Medication:
  • insulin
  • no incretin mimetics
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Hepatitis C Virus (HCV)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Anti-Human Immunodeficiency Virus-1/2 (HIV-1/2)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 7.90 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Hepatitis B Virus surface Antigen (HBsAg)
Qual: negative
Quant:
Source: this donation
negative
Method: CMIA (Chemiluminescence Micro Particle Immuno Assay)
System: Architect i 2000 sr Abbott
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH283429
1 mL ($43.13)
Available ($225.00)

Human Serum - Capsule-reactive protein (CRP), Eryth... - E11.90

Donor:
Gender: Female Age: 64 Ethnic group: European/Caucasian
Diagnosed disease:
E11.90
Medication:
Novaminsulfon
Parameter:
Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF)
Donor:
Gender:
Female
Age:
64 Years
Ethnic group:
European/Caucasian
BMI:
24 kg/m²
Weight:
68 kg
Height:
168 cm
Sample:
Matrix:
Serum
Condition:
slightly hemolytic
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • E11.90
Medication:
  • Novaminsulfon (as needed)
  • Prednisolon (Dosages: 2mg, as needed, active agent: glucocorticoid)
  • RoActemra (Dosages: 560mg/4 weeks, active agent: tocilizumab)
Parameter Result Ref. / Cut-Off Measuring Information
Capsule-reactive protein (CRP)
Qual:
Quant: 0.45 mg/L
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 5.00 mm/1h
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF)
Qual:
Quant: 152.00 IU/mL
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH240624
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Anti-cyclic citrullinated Peptide (CC... - E11.90

Donor:
Gender: Male Age: 64 Ethnic group: Asian
Diagnosed disease:
E11.90
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Total Rheumatoid Factor (tRF)
Donor:
Gender:
Male
Age:
64 Years
Ethnic group:
Asian
BMI:
23 kg/m²
Weight:
58 kg
Height:
160 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Anamneses:
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 8 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 8 (information given at the time of donation)
  • acute phase reaction (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (increased CRP or normal BSS)
  • duration of symptoms (ACR/EULAR criteria) Score: 1 (information given at the time of donation) (Longer than 6 weeks)
  • joint involvement (ACR/EULAR criteria) Score: 3 (4 to 10 small joints with or without involvement of big joints) (information given at the time of donation)
  • serology (ACR/EULAR criteria) Score: 3 (information given at the time of donation) (high positive RF or ACPA)
  • total points (ACR/EULAR criteria) 8 (information given at the time of donation)
Diseases:
  • E11.90
Medication:
  • Metex (Dosages: 10mg/week)
  • atorvastatin (Dosages: 40mg/day)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: positive
Quant: 350.00 IU/mL
Source: this donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Capsule-reactive protein (CRP)
Qual: negative
Quant: 2.85 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 30.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH303752
1 mL ($43.13)
Available ($225.00)
  • <
  • 1
  • ...
  • ...